pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,561 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 2
    JAG-201
    Autism Spectrum Disorder (ASD) Jaguar Gene Therapy LLC
  • Phase 2
    JBI-778
    Adenoid Cystic Carcinoma (ACC) Jubilant Therapeutics Inc
  • Phase 2
    JBI-802
    Neuroendocrine Tumors Jubilant Therapeutics Inc
  • Phase 2
← prev
page 16 of 53
next →
131
Pain89
Neurology1
JCXH-105
Herpes Zoster (Shingles)
Immorna Hangzhou Biotechnology Co Ltd
  • Phase 2
    JCXH-107
    Seasonal Influenza Immorna Hangzhou Biotechnology Co Ltd
  • Phase 2
    JCXH-221
    Coronavirus Disease 2019 (COVID-19) Immorna Hangzhou Biotechnology Co Ltd
  • Phase 2
    JIN-A02
    Non-Small Cell Lung Cancer J Ints Bio Co Ltd
  • Phase 2
    JK-07
    Diastolic Heart Failure (HFpEF) Salubris Biotherapeutics Inc
  • Phase 2
    JNJ-2056
    Alzheimer's Disease Johnson & Johnson Innovative Medicine
  • Phase 2
    JNS-101
    Friedreich Ataxia$JUNS JUPITER NEUROSCIENCES, INC.
  • Phase 2
    JWATM-204
    Hepatocellular Carcinoma Eureka Therapeutics Inc
  • Phase 2
    JadiCell ARDS
    Acute Respiratory Distress Syndrome Breathe Biologics Inc
  • Phase 2
    Jankistomig
    Solid Tumor Ottimo Pharma Ltd
  • Phase 2
    KB-707
    Metastatic Melanoma$KRYS Krystal Biotech, Inc.
  • Phase 2
    KB-801
    Neurotrophic Keratitis$KRYS Krystal Biotech, Inc.
  • Phase 2
    KBLP-001
    Plaque Psoriasis (Psoriasis Vulgaris) KoBioLabs Inc
  • Phase 2
    KETAMINE HYDROCHLORIDE
    KETAMINE HYDROCHLORIDE
    Major Depressive Disorder Seelos Therapeutics, Inc.
  • Phase 2
    KITE-363
    Diffuse Large B-Cell Lymphoma Kite Pharma Inc
  • Phase 2
    KITE-753
    Diffuse Large B-Cell Lymphoma$GILD GILEAD SCIENCES, INC.
  • Phase 2
    KK-8123
    X-Linked Hypophosphatemic Rickets Kyowa Kirin Co Ltd
  • Phase 2
    KL4 Surfactant
    Coronavirus Disease 2019 (COVID-19) Associated Acute Resp… Windtree Therapeutics Inc
  • Phase 2
    KLS-2031
    Neuropathic Pain (Neuralgia) Kolon Life Science Inc
  • Phase 2
    KM-819
    Parkinson's Disease Fascinate Therapeutics Inc
  • Phase 2
    KP-1077
    serdexmethylphenidate
    Idiopathic Hypersomnia (IH)$ZVRA ZEVRA THERAPEUTICS, INC.
  • Phase 2
    KSL-W
    Dental Plaque US Army Medical Research & Materiel Command
  • Phase 2
    KSQ-001
    Head And Neck Squamous Cell Carcinoma (HNSC) KSQ Therapeutics Inc
  • Phase 2
    KSQ-004
    Acral Lentiginous Melanoma KSQ Therapeutics Inc
  • Phase 2
    KT-621
    Eosinophilic Asthma$KYMR Kymera Therapeutics, Inc.
  • Phase 2
    KTP-001
    Lumbar Hernia/Bleichner's Hernia Teijin Pharma Ltd
  • Phase 2
    KUS-121
    Retinal Artery Occlusion Kyoto Drug Discovery & Development Co Ltd